Search results summary
From Health Canada
Search criteria
- Status: Select all
- AIG: 0106267011
Search results
Status | DIN | Company | Product | Class | PM See footnote1 | Schedule | # See footnote2 | A.I. name See footnote3 | Strength |
---|---|---|---|---|---|---|---|---|---|
Marketed | 02461692 | TAKEDA CANADA INC | CUVITRU | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Marketed | 02370352 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Marketed | 02463059 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Marketed | 02463067 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Marketed | 02498251 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Marketed | 02535424 | CSL BEHRING CANADA INC | HIZENTRA | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 200 MG / ML |
Approved | 02494426 | GRIFOLS THERAPEUTICS LLC | XEMBIFY | Human | Yes | Schedule D | 1 | IMMUNOGLOBULIN (HUMAN) | 20 % |
Application information
Related information
Contact us
Version 4.0.3